Scientists Discover New Treatment Target to Relieve Multiple Sclerosis Symptoms
An estimated 2.3 million people worldwide suffer from multiple sclerosis (MS), a disabling nervous system condition that can cause extreme pain, fatigue, and mobility difficulty. Severe cases of MS are disabling conditions eligible for Social Security disability benefits from the Social Security Administration (SSA).
While there is no known cure for MS, researchers have made great strides in developing drug therapies to reduce the symptoms and help patients live healthier, more fulfilling lives. A research team at the Centre for Addiction and Mental Health in Toronto may have discovered a new target for MS treatment.
Their study, published in the Annals of Clinical and Translational Neurology medical journal, explains that researchers found a common spinal cord alteration among animal models and deceased patients with MS. This alteration involves a protein that binds to glutamate, which is the most prominent neurotransmitter in the brain.
The team created a peptide that stopped the protein binding to the glutamate receptor. The result was improved neurological functioning in live animal models with MS. The treatment reduced nerve cell death and the protective myelin sheaths on the nerves were undamaged.
Similar treatments already exist, but many of these drug therapies suppress the immune system or interfere with nerve cell signaling. This new method of drug therapy that targets treatment directly at the spinal cord alteration could allow extended research and trials to develop a new medication for improving the lives of MS patients.
Multiple sclerosis causes many symptoms including fatigue, chronic pain, vision loss, muscle weakness, and tremors. This can exclude many MS patients from working at many occupations and over time keep them from working and earning a substantial income. Disability Help Group is here to help disabled individuals who are unable to work seek Social Security disability benefits. Call us at 1-(800)-800-3332 to review your claim.